Department of Health Management and Economics, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
Nursing Care Research Center, Semnan University of Medical Sciences, Semnan, Iran.
BMC Infect Dis. 2021 May 20;21(1):459. doi: 10.1186/s12879-021-06170-z.
COVID-19 is a public health emergency with a high mortality rate and it reduces the patient's Health-Related Quality of Life (HRQoL) significantly. This effect is measured in the current study.
In a cross-sectional study in Iran, 320 randomly selected treated patients from COVID-19 were studied. To collect the required data, we applied a questionnaire that included socio-demographic factors, clinical characteristics, and questions on the patients' HRQoL. Time trade-off (TTO) approach was used to measure the lost HRQoL attributed to COVID-19. Besides, we applied a two-limit Tobit regression model to determine the effects of the socio-demographic factors on patients' health utility and the visual analogue scale approach was used to estimate the perceived total current health status.
The overall mean (SE) and median (IQR) of the health utility values were 0.863 (0.01) and 0.909 (0.21) respectively. These values for the traders (those who were willing to lose a part of their remaining time of life to avoid the disease) were estimated at 0.793 (0.01) and 0.848 (0.17), respectively. The lowest amount of utility value belonged to the elderly (mean (SE) = 0.742 (0.04); median (IQR) = 0.765 (0.42)) and those living in rural areas (mean (SE)) = 0.804 (0.03); median (IQR) = 0.877 (0.30)). The univariate analysis showed that age, place of residence, and household size had a statistically significant effect on health utility. Moreover, findings of the regression analysis indicated that the participants' age and hospitalization status were the key determinants of COVID-19 health utility value.
COVID-19 is associated with a substantial and measurable decrease in HRQoL. This decline in HRQoL can be directly compared with that induced by systemic health states.
COVID-19 是一种公共卫生紧急事件,死亡率很高,严重降低了患者的健康相关生活质量(HRQoL)。本研究旨在测量这一影响。
在伊朗的一项横断面研究中,研究了 320 名随机选择的 COVID-19 治疗患者。为了收集所需数据,我们应用了一份问卷,其中包括社会人口统计学因素、临床特征以及患者 HRQoL 的问题。时间权衡(TTO)方法用于测量 COVID-19 导致的失去的 HRQoL。此外,我们应用了双限制 Tobit 回归模型来确定社会人口统计学因素对患者健康效用的影响,以及视觉模拟量表方法来估计当前感知的总体健康状况。
健康效用值的总体平均值(SE)和中位数(IQR)分别为 0.863(0.01)和 0.909(0.21)。对于愿意失去一部分剩余寿命来避免疾病的交易者,这些值估计为 0.793(0.01)和 0.848(0.17)。最低的效用值属于老年人(平均值(SE)= 0.742(0.04);中位数(IQR)= 0.765(0.42))和居住在农村地区的人(平均值(SE)= 0.804(0.03);中位数(IQR)= 0.877(0.30))。单因素分析表明,年龄、居住地和家庭规模对健康效用有统计学显著影响。此外,回归分析的结果表明,参与者的年龄和住院状况是 COVID-19 健康效用值的关键决定因素。
COVID-19 与 HRQoL 的显著和可测量的下降有关。这种 HRQoL 的下降可以与系统健康状况引起的下降直接进行比较。